|
1
|
Bigdelou B, Sepand MR, Najafikhoshnoo S,
Negrete JAT, Sharaf M, Ho JQ, Sullivan I, Chauhan P, Etter M,
Shekarian T, et al: COVID-19 and preexisting comorbidities: Risks,
synergies, and clinical outcomes. Front Immunol.
13(890517)2022.PubMed/NCBI View Article : Google Scholar
|
|
2
|
WHO: Tracking SARS-CoV-2 variants [EB/OL].
https://www.who.int/en/activities/tracking-SARS-CoV-2-variants/.
Accessed December 9, 2021.
|
|
3
|
Yadav PD, Kumar G, Mukherjee A, Nyayanit
DA, Shete AM, Sahay RR, Kumar A, Majumdar T, Patil S, Pandit P, et
al: Delta variant SARS-CoV-2 infections in pediatric cases during
the second wave in India. J Microbiol Immunol Infect.
2:S1684–S1182. 2022.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Pal R and Yadav U: Resurgence of COVID-19
in India: Time for introspection. Postgrad Med J. 98:e86–e87.
2022.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Calistri P, Amato L, Puglia I, Cito F, Di
Giuseppe A, Danzetta ML, Morelli D, Di Domenico M, Caporale M,
Scialabba S, et al: Infection sustained by lineage B.1.1.7 of
SARS-CoV-2 is characterised by longer persistence and higher viral
RNA loads in nasopharyngeal swabs. Int J Infect Dis. 105:753–755.
2021.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Jansen L, Tegomoh B, Lange K, Showalter K,
Figliomeni J, Abdalhamid B, Iwen PC, Fauver J, Buss B and Donahue
M: Investigation of a SARS-CoV-2 B.1.1.529 (Omicron) variant
cluster-nebraska, November-December 2021. MMWR Morb Mortal Wkly
Rep. 70:1782–1784. 2021.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Ulloa AC, Buchan SA, Daneman N and Brown
KA: Estimates of SARS-CoV-2 Omicron variant severity in Ontario,
Canada. Jama. 327:1286–1288. 2022.PubMed/NCBI View Article : Google Scholar
|
|
8
|
National Health and Wellness Commission of
the People's Republic of China. Treatment protocol for novel
coronavirus pneumonia (trial version, eighth edition, revised):
81-88, 2020. Accessed August 18, 2020.
|
|
9
|
Nyberg T, Ferguson NM, Nash SG, Webster
HH, Flaxman S, Andrews N, Hinsley W, Bernal JL, Kall M, Bhatt S, et
al: Comparative analysis of the risks of hospitalisation and death
associated with SARS-CoV-2 Omicron (B.1.1.529) and delta
(B.1.617.2) variants in England: A cohort study. Lancet.
399:1303–1312. 2022.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Smith DJ, Hakim AJ, Leung GM, Xu W,
Schluter WW, Novak RT, Marston B and Hersh BS: COVID-19 mortality
and vaccine coverage-Hong Kong special administrative region,
China, January 6, 2022-March 21, 2022. MMWR Morb Mortal Wkly Rep.
71:545–548. 2022.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Bechmann N, Barthel A, Schedl A, Herzig S,
Varga Z, Gebhard C, Mayr M, Hantel C, Beuschlein F, Wolfrum C, et
al: Sexual dimorphism in COVID-19: Potential clinical and public
health implications. Lancet Diabetes Endorincol. 10:221–230.
2022.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Sama IE, Ravera A, Santema BT, van Goor H,
Ter Maaten JM, Cleland JGF, Rienstra M, Friedrich AW, Samani NJ, Ng
LL, et al: Circulating plasma concentrations of
angiotensin-converting enzyme 2 in men and women with heart failure
and effects of renin-angiotensin-aldosterone inhibitors. Eur Heart
J. 41:1810–1817. 2020.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Wan YI, Apea VJ, Dhairyawan R, Puthucheary
ZA, Pearse RM, Orkin CM and Prowle JR: Ethnic disparities in
hospitalisation and hospital-outcomes during the second wave of
COVID-19 infection in east London. Sci Rep. 12(3721)2022.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Maslo C, Friedland R, Toubkin M, Laubscher
A, Akaloo T and Kama B: Characteristics and outcomes of
hospitalized patients in South Africa during the COVID-19 omicron
wave compared with previous waves. JAMA. 327:583–584.
2022.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Iacobucci G: Covid-19: Runny nose,
headache, and fatigue are commonest symptoms of omicron, early data
show. BMJ. 375(n3103)2021.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Kupferschmidt K and Vogel G: Omicron
threat remains fuzzy as cases explode. Science. 375:9–10.
2022.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Graham F: Daily briefing: Omicron
struggles to infect the lungs. Nature. 6(1038)2022.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Cowper A: Omicron: Who needs action when
you've got plan B? BMJ. 376(o15)2022.PubMed/NCBI View
Article : Google Scholar
|
|
19
|
Halfmann PJ, Iida S, Iwatsuki-Horimoto K,
Maemura T, Kiso M, Scheaffer SM, Darling TL, Joshi A, Loeber S,
Singh G, et al: SARS-CoV-2 Omicron virus causes attenuated disease
in mice and hamsters. Nature. 603:687–92. 2022.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Menni C, Valdes AM, Polidori L, Antonelli
M, Penamakuri S, Nogal A, Louca P, May A, Figueiredo JC, Hu C, et
al: Symptom prevalence, duration, and risk of hospital admission in
individuals infected with SARS-CoV-2 during periods of Omicron and
delta variant dominance: A prospective observational study from the
ZOE COVID study. Lancet. 399:1618–1624. 2022.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J,
Wang B, Xiang H, Cheng Z, Xiong Y, et al: Clinical characteristics
of 138 hospitalized patients with 2019 novel coronavirus-infected
pneumonia in Wuhan, China. JAMA. 323:1061–1069. 2020.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Wang F, Hou H, Yao Y, Wu S, Huang M, Ran
X, Zhou H, Liu Z and Sun Z: Systemically comparing host immunity
between survived and deceased COVID-19 patients. Cell Mol Immunol.
17:875–877. 2020.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Refaat L, Abdellateif MS, Bayoumi A,
Khafagy M, Kandeel EZ and Nooh HA: Detection of abnormal
lymphocytes in the peripheral blood of COVID-19 cancer patients:
Diagnostic and prognostic possibility. Hematology. 27:745–756.
2022.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Li R, Tian J, Yang F, Lv L, Yu J, Sun G,
Ma Y, Yang X and Ding J: Clinical characteristics of 225 patients
with COVID-19 in a tertiary hospital near Wuhan, China. J Clin
Virol. 127(104363)2020.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Milenkovic M, Hadzibegovic A, Kovac M,
Jovanovic B, Stanisavljevic J, Djikic M, Sijan D, Ladjevic N,
Palibrk I, Djukanovic M, et al: D-dimer, CRP, PCT, and IL-6 levels
at admission to ICU can predict in-hospital mortality in patients
with COVID-19 pneumonia. Oxid Med Cell Longev.
2022(8997709)2022.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Fang S, Wang H, Lu L, Jia Y and Xia Z:
Decreased complement C3 levels are associated with poor prognosis
in patients with COVID-19: A retrospective cohort study. Int
Immunopharmacol. 89(107070)2020.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Tang N, Li D, Wang X and Sun Z: Abnormal
coagulation parameters are associated with poor prognosis in
patients with novel coronavirus pneumonia. J Thromb Haemos.
18:844–847. 2020.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Lin P, Chen W, Huang H, Lin Y, Cai M, Lin
D, Cai H, Su Z, Zhuang X and Yu X: Delayed discharge is associated
with higher complement C3 levels and a longer nucleic acid-negative
conversion time in patients with COVID-19. Sci Rep.
11(1233)2021.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Jiang H, Chen Q, Zheng S, Guo C, Luo J,
Wang H, Zheng X and Weng Z: Association of complement C3 with
clinical deterioration among hospitalized patients with COVID 19.
Int J Gen Med. 15:849–857. 2002.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Zinellu A and Mangoni AA: Serum complement
C3 and C4 and COVID-19 severity and mortality: A systematic review
and meta-analysis with meta-regression. Front Immunol.
12(696085)2021.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Lin Y, Zhao Z, Zheng J, Liu J and Huang A:
Realization of humoral immunity against SARS-CoV-2 infections. J
Fundamental Research. 1:186–188. 2021.
|
|
32
|
Yu HQ, Sun BQ, Fang ZF, Zhao JC, Liu XY,
Li YM, Sun XZ, Liang HF, Zhong B, Huang ZF, et al: Distinct
features of SARS-CoV-2-specific IgA response in COVID-19 patients.
Eur Respir J. 56(2001526)2020.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Zhou C, Bu G, Sun Y, Ren C, Qu M, Gao Y,
Zhu Y, Wang L, Sun L and Liu Y: Evaluation of serum IgM and IgG
antibodies in COVID-19 patients by enzyme linked immunosorbent
assay. J Med Virol. 93:2857–2866. 2021.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Xu L, Liu J, Lu M, Yang D and Zheng X:
Liver injury during highly pathogenic human coronavirus infections.
Liver Int. 40:998–1004. 2020.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Diaz-Louzao C, Barrera-Lopez L,
Lopez-Rodriguez M, Casar C, Vazquez-Agra N, Pernas-Pardavila H,
Marques-Afonso A, Vidal-Vazquez M, Montoya JG, Andrade AH, et al:
Longitudinal relationship of liver injury with inflammation
biomarkers in COVID-19 hospitalized patients using a joint modeling
approach. Sci Rep. 12(5547)2022.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Lui VC, Hui KP, Babu RO, Yue H, Chung PH,
Tam PK, Chan MCW and Wong KKY: Human liver organoid derived
intra-hepatic bile duct cells support SARS-CoV-2 infection and
replication. Sci Rep. 12(5375)2022.PubMed/NCBI View Article : Google Scholar
|
